57 related articles for article (PubMed ID: 38580756)
21. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
22. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.
Okumura T; Ikeda K; Ujihira T; Okamoto K; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2018 Jan; 163(1):19-29. PubMed ID: 28992264
[TBL] [Abstract][Full Text] [Related]
23. The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target.
Cromm PM; Crews CM
ACS Cent Sci; 2017 Aug; 3(8):830-838. PubMed ID: 28852696
[TBL] [Abstract][Full Text] [Related]
24. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
25. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Tang Z; Li C; Kang B; Gao G; Li C; Zhang Z
Nucleic Acids Res; 2017 Jul; 45(W1):W98-W102. PubMed ID: 28407145
[TBL] [Abstract][Full Text] [Related]
26. Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11.
Li J; Yakushi T; Parlati F; Mackinnon AL; Perez C; Ma Y; Carter KP; Colayco S; Magnuson G; Brown B; Nguyen K; Vasile S; Suyama E; Smith LH; Sergienko E; Pinkerton AB; Chung TDY; Palmer AE; Pass I; Hess S; Cohen SM; Deshaies RJ
Nat Chem Biol; 2017 May; 13(5):486-493. PubMed ID: 28244987
[TBL] [Abstract][Full Text] [Related]
27. An atomic structure of the human 26S proteasome.
Huang X; Luan B; Wu J; Shi Y
Nat Struct Mol Biol; 2016 Sep; 23(9):778-85. PubMed ID: 27428775
[TBL] [Abstract][Full Text] [Related]
28. Structure of the human 26S proteasome at a resolution of 3.9 Å.
Schweitzer A; Aufderheide A; Rudack T; Beck F; Pfeifer G; Plitzko JM; Sakata E; Schulten K; Förster F; Baumeister W
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7816-21. PubMed ID: 27342858
[TBL] [Abstract][Full Text] [Related]
29. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers.
Schwertman P; Bekker-Jensen S; Mailand N
Nat Rev Mol Cell Biol; 2016 May; 17(6):379-94. PubMed ID: 27211488
[TBL] [Abstract][Full Text] [Related]
30. Molecular architecture and assembly of the eukaryotic proteasome.
Tomko RJ; Hochstrasser M
Annu Rev Biochem; 2013; 82():415-45. PubMed ID: 23495936
[TBL] [Abstract][Full Text] [Related]
31. Effect of Y220C mutation on p53 and its rescue mechanism: a computer chemistry approach.
Rauf SM; Endou A; Takaba H; Miyamoto A
Protein J; 2013 Jan; 32(1):68-74. PubMed ID: 23315175
[TBL] [Abstract][Full Text] [Related]
32. NOXA, a sensor of proteasome integrity, is degraded by 26S proteasomes by an ubiquitin-independent pathway that is blocked by MCL-1.
Craxton A; Butterworth M; Harper N; Fairall L; Schwabe J; Ciechanover A; Cohen GM
Cell Death Differ; 2012 Sep; 19(9):1424-34. PubMed ID: 22361683
[TBL] [Abstract][Full Text] [Related]
33. The 26S proteasome complex: an attractive target for cancer therapy.
Frankland-Searby S; Bhaumik SR
Biochim Biophys Acta; 2012 Jan; 1825(1):64-76. PubMed ID: 22037302
[TBL] [Abstract][Full Text] [Related]
34. Proteasome inhibitors in cancer therapy.
Crawford LJ; Walker B; Irvine AE
J Cell Commun Signal; 2011 Jun; 5(2):101-10. PubMed ID: 21484190
[TBL] [Abstract][Full Text] [Related]
35. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
[TBL] [Abstract][Full Text] [Related]
36. Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents.
Takeshita T; Wu W; Koike A; Fukuda M; Ohta T
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1039-46. PubMed ID: 19274461
[TBL] [Abstract][Full Text] [Related]
37. The proteasome: overview of structure and functions.
Tanaka K
Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(1):12-36. PubMed ID: 19145068
[TBL] [Abstract][Full Text] [Related]
38. Role of proteasomes in cellular regulation.
Konstantinova IM; Tsimokha AS; Mittenberg AG
Int Rev Cell Mol Biol; 2008; 267():59-124. PubMed ID: 18544497
[TBL] [Abstract][Full Text] [Related]
39. Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation.
Liu WH; Hsiao HW; Tsou WI; Lai MZ
EMBO J; 2007 Mar; 26(6):1660-9. PubMed ID: 17318174
[TBL] [Abstract][Full Text] [Related]
40. Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics.
Deng S; Zhou H; Xiong R; Lu Y; Yan D; Xing T; Dong L; Tang E; Yang H
Breast Cancer Res Treat; 2007 Jul; 104(1):21-30. PubMed ID: 17004105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
